Trademark: 86902020
Word
VIUM
Status
Dead
Status Code
606
Status Date
Monday, November 4, 2019
Serial Number
86902020
Mark Type
4000
Filing Date
Tuesday, February 9, 2016
Published for Opposition
Tuesday, August 9, 2016
Abandoned Date
Monday, November 4, 2019

Trademark Owner History
VIUM, INC. - 1st New Owner After Publication
Mousera, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of rheumatoid arthritis, osteoarthritis, pain, multiple sclerosis, inflammatory disease, cancer, and CNS disorders
42 Laboratory analysis in the field of genotyping and phenotyping of animals, laboratory animal scientific research and testing; laboratory research in the field of genotyping and phenotyping of animals; scientific laboratory services; scientific research and development; scientific research consulting in the field of genotyping and phenotyping of animals; laboratory animal scientific research and testing and avian egg development and; agrochemicals, pharmaceuticals, biologics, agrochemicals, pharmaceuticals, biologics; biopharmaceutical research design and scientific testing services; pharmaceuticals, biopharmaceuticals, and biologics; pharmaceuticals, and medical devices for the presence of endotoxins; animal medical research and testing services and avian egg development and testing services for the purpose of medical research; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; platform as a service (PAAS) featuring computer software platforms for conducting preclinical research in the field of animal and human scientific research and testing and development of pharmaceuticals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, phenotyping, and genetic profiling; computer hardware and software design; development, updating and maintenance of software and databases; animal and non-clinical pharmaceutical and and clinical and pharmaceuticals and medical devices; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals and clinical trials; providing online non-downloadable software for designing, conducting, analyzing, and reporting animal studies
44 Genetic testing of eggs; Medical services in the fields of pathology, pharmacology, and immunology; medical and psychological counseling; providing medical information and advice in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical trials and studies on medical devices

Trademark Events
Nov 4, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 4, 2019
Abandonment - No Use Statement Filed
Oct 11, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 4, 2019
Extension 5 Granted
Apr 4, 2019
Extension 5 Filed
Apr 11, 2019
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 4, 2019
Teas Extension Received
Nov 20, 2018
Corrected Noa E-Mailed
Nov 19, 2018
Divisional Processing Complete
Oct 4, 2018
Divisional Request Received
Nov 17, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2018
Teas Response To Office Action Received
Nov 16, 2018
Itu Office Action Issued For Divisional Request
Oct 4, 2018
Extension 4 Granted
Oct 4, 2018
Extension 4 Filed
Oct 4, 2018
Teas Request To Divide Received
Oct 4, 2018
Teas Extension Received
Apr 6, 2018
Notice Of Approval Of Extension Request E-Mailed
Apr 4, 2018
Extension 3 Granted
Apr 4, 2018
Extension 3 Filed
Apr 4, 2018
Teas Extension Received
Oct 6, 2017
Notice Of Approval Of Extension Request E-Mailed
Oct 4, 2017
Extension 2 Granted
Oct 4, 2017
Extension 2 Filed
Oct 4, 2017
Teas Extension Received
Apr 21, 2017
Notice Of Approval Of Extension Request E-Mailed
Apr 21, 2017
Corrected Noa E-Mailed
Apr 20, 2017
Divisional Processing Complete
Mar 30, 2017
Divisional Request Received
Apr 20, 2017
Extension 1 Granted
Mar 30, 2017
Extension 1 Filed
Apr 20, 2017
Case Assigned To Intent To Use Paralegal
Mar 30, 2017
Teas Request To Divide Received
Mar 30, 2017
Teas Extension Received
Oct 4, 2016
Noa E-Mailed - Sou Required From Applicant
Aug 10, 2016
Automatic Update Of Assignment Of Ownership
Aug 9, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 9, 2016
Published For Opposition
Jul 20, 2016
Notification Of Notice Of Publication E-Mailed
Jul 5, 2016
Law Office Publication Review Completed
Jun 26, 2016
Approved For Pub - Principal Register
Jun 23, 2016
Teas/Email Correspondence Entered
Jun 23, 2016
Correspondence Received In Law Office
Jun 22, 2016
Assigned To Lie
Jun 15, 2016
Teas Response To Office Action Received
Jun 2, 2016
Notification Of Non-Final Action E-Mailed
Jun 2, 2016
Non-Final Action E-Mailed
Jun 2, 2016
Non-Final Action Written
May 25, 2016
Assigned To Examiner
Feb 12, 2016
New Application Office Supplied Data Entered In Tram
Feb 12, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24